Baseline clinical characteristics*
| Patients (n = 10) | Controls (n = 11) | p value | |
|---|---|---|---|
| *Data represent mean (SD), or number of persons (percentage in parenthesis). | |||
| †One control had recently fallen, due to environmental circumstances. | |||
| NS, not significant. | |||
| Age (years) | 63.7 (6.1) | 68.1 (4.8) | NS |
| No. of women (%) | 5 (50%) | 6 (55%) | NS |
| Height (m) | 1.7 (0.1) | 1.7 (0.1) | NS |
| Weight (kg) | 70.4 (12.6) | 76.2 (13.1) | NS |
| Duration of disease (years) | 10.4 (7.2) | – | – |
| Fallers (⩽3 months) | 6 (60%) | 1 (9.1%)† | p = 0.07 |
| Fear of falling | 6 (60%) | 1 (9.1%) | p = 0.07 |
| Activities-specific Balance Confidence Scale (%) | 62 (19) | 89 (11) | p<0.01 |
| Medication | |||
| Levodopa/carbidopa | 9 (90%) | – | |
| Dopamine receptor agonist | 8 (80%) | – | |
| Amantadine | 8 (80%) | – | |
| Anticholinergic | 4 (40%) | – | |
| Other | – | ||
| Benzodiazepine | 4 (40%) | – | |
| Clozapine | 4 (40%) | – | |
| Cisapride | 1 (10%) | – | |
| Omeprazole | 1 (10%) | 1 (9.1%) | |
| Diuretics | 0 (0%) | 1 (9.1%) | |